共 266 条
[1]
Sue Huang Q(2021)Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand Nat Commun 12 1001-2074
[2]
Wood T(2020)Bacterial and fungal superinfections in critically ill patients with COVID-19 Intensive Care Med 46 2071-88
[3]
Jelley L(2021)State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia Infection 27 83-128
[4]
Jennings T(2021)Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study Clin Microbiol Infect 8 ofaa640-401
[5]
Jefferies S(2020)Histological evidence of pulmonary microthrombosis and vasculitis in life-threatening respiratory virus diseases Open Forum Infect Dis 383 120-7
[6]
Daniells K(2020)Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 N Engl J Med 127 400-792
[7]
Bassetti M(2020)Hypoalbuminemia, coagulopathy, and vascular disease in COVID-19 Circ Res 28 1-1535
[8]
Kollef MH(2020)Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature Infection 6 782-1509
[9]
Timsit JF(2019)Survival during influenza-associated bacterial superinfection improves following viral- and bacterial-specific monoclonal antibody treatment JCI Insight 46 1524-e55
[10]
Chong WH(2021)Ventilator-associated bacterial pneumonia in coronavirus 2019 disease, a retrospective monocentric cohort study J Infect Chemother 25 1501-e49